Categories AlphaGraphs, Earnings, Health Care
Johnson & Johnson (JNJ) Q3 2024 Earnings: Key financials and quarterly highlights
Johnson & Johnson (NYSE: JNJ) reported its third quarter 2024 earnings results today.
Reported sales increased 5.2% year-over-year to $22.5 billion.
GAAP earnings decreased 37.5% to $2.7 billion while EPS fell 34% to $1.11 compared to last year. Adjusted EPS was down 9% to $2.42.
Revenue and earnings beat expectations.
For full-year 2024, JNJ expects reported sales of $88.4-88.8 billion and adjusted EPS of $9.88-9.98.
The stock was down 1% in premarket hours on Tuesday.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Key highlights from Nio’s (NIO) Q3 2024 earnings results
NIO Inc. (NYSE: NIO) reported its third quarter 2024 earnings results today. Total revenues were $2.66 billion, down 2.1% from the same period a year ago. Net loss attributable
Key takeaways from Walmart’s (WMT) Q3 2025 report
Over the years, Walmart Inc. (NYSE: WMT) has followed a successful business model focused on offering customers a unique shopping experience and the best prices. While the retail giant continues
What to look for when Macy’s (M) reports its Q3 2024 earnings results
Shares of Macy’s, Inc. (NYSE: M) remained red on Tuesday. The stock has dropped 14% over the past three months. The retailer is scheduled to report its third quarter 2024
